BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 25, 2010
 |  BC Week In Review  |  Company News  |  Deals

GenVec, Novartis deal

GenVec granted Novartis exclusive, worldwide rights to GenVec's preclinical hearing loss and balance disorders program. The program uses GenVec's adenovector technology to deliver atonal homolog 1...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >